Newsroom
Sorted by: Latest
-
Siemens dévoile des technologies destinées à accélérer la révolution de l'IA industrielle lors du CES 2026
LAS VEGAS--(BUSINESS WIRE)--Lors du CES 2026, le discours d'ouverture de Siemens a marqué le début d'une nouvelle ère technologique pour l'industrie et les infrastructures, en montrant comment les clients et les partenaires exploitent l'intelligence artificielle pour transformer leurs activités. Grâce à des technologies basées sur l'IA, une expertise approfondie dans son domaine et des partenariats de confiance, Siemens convertit cette avancée technologique en avantages mesurables pour ses clie...
-
Franklin Resources, Inc. Announces Preliminary Month-End Assets Under Management
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Resources, Inc. Announces Preliminary Month-End Assets Under Management...
-
Neptune Flood Announces New Capacity Partnership with Somers Syndicate at Lloyd’s
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Neptune Flood, the leading provider of private flood insurance in the US, partners with Somers Syndicate 3705 to add additional underwriting capacity....
-
ZIIHERA Plus TEVIMBRA e quimioterapia: Um potencial novo padrão para o tratamento de primeira linha do GEA HER2+ avançado
SAN CARLOS, Califórnia--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), uma empresa global de oncologia, anunciou hoje os resultados completos do estudo de Fase 3 HERIZON-GEA-01, que avaliou o ZIIHERA® (zanidatamab), um anticorpo biespecífico direcionado ao HER2, em combinação com quimioterapia, com e sem o inibidor de PD-1 TEVIMBRA® (tislelizumabe), como tratamento de primeira linha para adenocarcinoma gastroesofágico (GEA) HER2-positivo (HER2+) localmente avança...
-
Heitman Acquires Nine Asset Residential Portfolio in Fukuoka, Japan
TOKYO--(BUSINESS WIRE)--Heitman LLC (“Heitman”), a global real estate investment management firm, today announced the acquisition of a nine-asset residential portfolio in Fukuoka, Japan. The investment was executed by Heitman on behalf of its global core-plus strategy and Heitman’s strategic capital partner SMFL MIRAI Partners Company, Limited (“SMFL MIRAI Partners”), which is a strategic subsidiary of Sumitomo Mitsui Finance and Leasing Company, Limited. The transaction marks the largest multi...
-
Heitman Acquires Tosu Central Distribution Center in Fukuoka Logistics Hub
TOKYO--(BUSINESS WIRE)--Heitman LLC (“Heitman”), a global real estate investment management firm, today announced the acquisition of the Tosu Central Distribution Center (“Tosu Central DC”), located within one of Kyushu’s prime logistics hubs. The transaction marks the largest ever single-asset logistics transaction in the greater Fukuoka market. The investment was executed by Heitman on behalf of its funds under management and Heitman’s strategic capital partners Mitsubishi HC Capital Realty I...
-
LRN Appoints Bob Lemmond as Chief Executive Officer
NEW YORK--(BUSINESS WIRE)--LRN Corporation, a global leader in ethics and compliance technology and solutions, today appointed Bob Lemmond as Chief Executive Officer. Lemmond will also join the company’s Board of Directors. For more than three decades, LRN has set the standard in ethics and compliance—shaping the category through unmatched expertise and technology. LRN focuses on inspiring principled performance, strengthening cultures, and elevating behavior for more than 2,500 organizations w...
-
KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-1 (SEMT 2026-1)
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 76 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-1 (SEMT 2026-1), a $672.1 million prime RMBS transaction. The pool is comprised of 546 first-lien, fully amortizing fixed rate mortgages with mostly 30-year maturity terms. The collateral is characterized by a weighted average(WA) original credit score of 779 and moderate borrower equity, with a WA original LTV of 71.8% and WA original CLTV of 71.8%. K...
-
Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its intention to offer, subject to market and other conditions, $500 million aggregate principal amount of convertible senior notes due 2032 (the “notes”) and $200 million of common stock in separate public offerings registered under the Securities Act of 1933, as amended. Arrowhead also expects to grant the underwriters of the note offering a 30-day option to purchase up to an additional $75 milli...
-
Aspect Announces CEO Leadership Transition and New Independent Board
DENVER--(BUSINESS WIRE)--Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspec...